{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Serotonin Agonist" in comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
Aptazapine maleate by ZYF Pharm Chemical
Source URL:
Class (Stereo):
CHEMICAL (RACEMIC)
Aptazapine is a “non-classic” tetracyclic antidepressant drug. Compound bears a structural resemblance to mianserin. Aptazapine possesses a high degree of potency and selectivity for central alpha-2, as opposed to alpha-1, adrenoceptors. Aptazapine failed to inhibit in vitro uptake of norepinephrine or serotonin to an appreciable extent. However, it exhibited a moderate ability to compete for 5-HT2 receptor binding in calf frontal cortex, as measured by displacement of 3H-spiroperidol. Another property apparently shared with other antidepressants is the ability of aptazapine to inhibit histamine-activated adenyl cyclase. As centrally acting alpha-2 adrenoceptor antagonists, aptazapine significantly suppressed cataplexy, a major symptom of narcolepsy, in Doberman pinschers.